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ABSTRACT
Macrophages are a type of immune cell responsible for engulfing cellular debris,
pathogens and cancer cells along with assisting the wound healing process. They have two
extreme phenotypes: one that can be induced by lipopolysaccharide called classically activated
M1 macrophages and another one that can be activated by interleukin-4 called alternatively
activated M2 macrophages. Macrophages secrete different cytokines and chemokines, depending
on their phenotype. M1 macrophages can help activate the immune response and destroy
transformed cells while M2 macrophages will promote tumor cell growth. Tumor associated
macrophages (TAMs) are thought to adopt an M2 phenotype and are associated with poor
prognosis. Thus, TAMs as drug targets have the potential to improve cancer outcomes.
Chemically modified poly (N-isopropylacrylamide) (pNIPAm) particles were used as the drug
delivery vehicle in this study. These particles exhibit good biocompatibility and a phase
transition temperature that enables drug loading at room temperature. Due to the lower critical
solution temperature of pNIPAm, the polymer swells at temperatures below 32-34°C. Therefore,
drugs loaded into pNIPAm particles at room temperature can be slowly released when in the
body. In this study, 13 different modifiers were covalently attached to pNIPAm particles and
their synergy in promoting internalization was studied. By studying the internalization ability of
different surface functional groups, we can gain a further understanding for rational design of
drug delivery systems.
1CHAPTER 1 INTRODUCTION
1.1 The Role of Macrophages in Immune Response
Macrophages are immune cells that provide the first line of defense to protect the host
from infection. They differentiate from monocytes, which derive from myeloid progenitor cells
and circulate in the blood stream. Once those cells mature into macrophages they will reside in
all tissue types. Macrophages are “big eaters” in the immune system because they can engulf,
digest, and remove large molecules, cellular debris, and foreign substances, as well as dead
cells.1 This process is called phagocytosis, which based on the recognition of foreign substances
through various pattern recognition receptors.2 Implanted biomaterials with a size larger than 0.5
µm can also trigger the macrophage phagocytosis based on the interaction between ligands on
the material and the cell surface receptors.3 Furthermore, macrophages do not merely protect the
host and interact with the invading materials, but also produce functional proteins and respond to
signals secreted by other cells. They can induce a variety of cytokines, chemokines and growth
factors to function in microbial killing, angiogenesis development, as well as immune
regulation.3 Meanwhile, other immune cells can signal macrophages to amplify their
inflammatory response or help the wound healing process.2
1.2 Macrophage Phenotypes and Their Role in Tumor Growth
Plasticity is a hallmark of macrophages with environmental cues stimulating each
phenotype. The wide range of chemokines and cytokines secreted by macrophages of each
phenotype plays distinct functions through signaling and regulating other cell and tissue
activities, such as inflammation; tissue repair and regeneration; and tumor progression and
suppression.4,5 These different phenotypes can be described as a color wheel as described by
Mosser and Edwards.6 Figure 1.1 shows the classification and activation of the three basic
2phenotypes according to their fundamental function: classically activated macrophages (M1
macrophages), alternatively activated macrophages (M2 macrophages), and regulatory
macrophages.
Figure 1.1. Color wheel of macrophage activation. The three populations of macrophages that
are discussed in this article are arranged according to the three primary colors, with red
designating M1 macrophages, yellow designating M2 macrophages and blue designating
regulatory macrophages. Secondary colors, such as green, may represent tumor-associated
macrophages, which have many characteristics of regulatory macrophages but also share some
characteristics of M2 macrophages. (Figure and text from6)
M1 macrophages can be induced by the interferon-γ (IFN-γ), lipopolysaccharide (LPS)
and tumor necrosis factor-α (TNF-α).2,7 They are characterized by high levels of interleukin-12
(IL-12), inducible nitric oxide synthase, TNF-α, and a low levels of IL-10.5,7 M1 macrophages
also produce inflammatory chemokines, such as macrophage inflammatory protein (MIP)-3α
(CCL20) and B cell attracting chemokine-1 (CXCL13).4 These chemokines can act on other
3immune cells, such as natural killer cells, to amplify the inflammatory response.4 These
characteristics allow M1 macrophages to ward off bacteria, stimulate inflammatory responses
during wound healing, and suppress tumor growth. After the recognition and binding with tumor
cells, the TNF-α and nitric oxide secreted by M1 macrophages can kill tumor cells.8 Additionally,
macrophages can also present tumor antigens to T cells to activate an immune response and
further destroy cancer cells.9 Granulocyte-macrophage colony-stimulating factor (GM-CSF) and
M-CSF, similar to IFN-γ, are cytokines generated by T cells to activate M1 macrophages and
upregulate cytotoxic cytokines to kill cancer cells.8
In contrast, M2 macrophages are another macrophage phenotype that can promote
tumorigenesis by collaborating with regulatory T lymphocytes to affect tissue response,
promoting wound healing, antagonizing the M1 response to decrease inflammatory effects, and
suppressing their antitumor responses.2,10 They are directly induced by IL-4, IL-13, and IL-10.11
These cells are characterized by a low production of IL-12 and other pro-inflammatory cytokines,
such as TNF-α and IL-6, as well as a high production of IL-10 and immunosuppressive
cytokines.5,12 These molecules can result in a T helper 2 response, which can increase IL-4
production and contribute to wound healing.5 IL-10 promotes tumor growth by suppressing the
activities of natural killer and T helper 1 cells to reduce the cytotoxicity of the tumor
microenvironment.5 Figure 1.2 shows the polarization and function of M1 and M2
macrophages.13
4Figure 1.2. Polarization of macrophage function. Macrophages constitute an extremely
heterogeneous population, which could be divided schematically into two main classes: M1 and
M2. Blood monocytes differentiating in the presence of LPS/IFN-γ mature into M1-polarized
cells. They produce high levels of IL-12, IL-1, IL-23, TNF-α and CXCL10 and are characterized
by cytotoxic activity against microorganisms and neoplastic cells, expression of high levels of
ROI, and capability as APCs. On the other hand, when monocytes differentiate in the presence of
IL-4, IL-13, IL-10 or corticosteroids, they mature into M2 macrophages, which secrete IL-10,
CCL17, CCL22, CCL18, IL-1ra and IL-1R decoy. M2 cells are active workers of the host,
promoting scavenging of debris, angiogenesis, remodeling, and repair of wounded/damaged
tissue. Within the tumor mass, they exert the same functions favoring tumor promotion. In
addition, M2 macrophages control the inflammatory response by down-regulating M1-mediated
functions and adaptive immunity. (Figure and text from13)
5TAMs are functionally similar M2 macrophages, They are found in close proximity to
tumor cells and promote tumor growth, which make them a potential tumor therapeutic
target.13,14 Tumor and stromal cells can secrete chemokines such as CC ligand (CCL)2, vascular
endothelial growth factor (VEGF), and IL-10 to aid the differentiation process of monocytes to
TAMs and the recruitment of TAMs to tumor masses.5 Similarly, TAMs can produce IL-10,
which suppresses the immune response by inhibiting production of inflammatory cytokines and
preventing the anti-tumor function of T helper cells and T cells, and finally, enhance tumor
growth.5,13,15 Through the production of IL-23, transforming growth factor-β (TGF-β), and
VEGF, as well as angiogenesis-regulating enzymes matrix metalloproteinases (MMPs), TAMs
aid in angiogenesis, and degrade proteins to promote metastasis.5,13,16 For example, MMPs
degrade the basement membrane which results in enhanced cell mobility and an alteration in
cell-cell adhesion.15,17 Figure 1.3 shows the role TAMs play in tumor growth.
In the United States, 1,685,210 new cancer cases and 595,690 cancer deaths are predicted
for 2016, according to the American Cancer Society.19 There has been a decline in cancer death
rates during the last two decades with the exception of liver and pancreatic cancers, which show
increasing death rates.19 TAMs are associated with poor prognosis in many types of cancer.5
Therefore, more effective therapies are needed. For cancer therapy, chemotherapy has been the
gold standard.20 However, a major limitation lies in the toxicity of most chemotherapeutics,
which results in a narrow therapeutic window.21 One method to avoid significant toxicity is by
adding inhibitors such as bisphosphonate zoledronic acid to slow tumor growth or prevent
monocyte recruitment to tumor sites.13,15,22 Currently, many studies focus on using the pro-
inflammatory characteristics of macrophages to treat tumors. One approach is to use
macrophages as vectors to deliver drugs to tumor sites. Macrophages were transfected with anti-
6tumor genes to deliver therapeutic molecules to the tumor.5,15 Reprograming M2 macrophages to
an M1 state is another potential method for improving current chemotherapeutic outcomes.13,21
Activation of toll-like receptors (TLRs) on macrophages can trigger an M1 response. Previous
studies showed that anti-IL-10 receptor antibodies attached the ligand 5’-C-phophate-G-3’ (CpG)
can activate TLRs, stimulate an M1 response, and transform M2 macrophages to M1
effectively.23,24
Figure 1.3. Tumour-derived chemotactic factors (CC-chemokines, e.g. CCL2), macrophage
colony stimulating factor (M-CSF) and vascular endothelial growth factor (VEGF), actively
recruit circulating blood monocytes at the tumour site. In the tumour micro-environment
monocytes differentiate into tumour-associated macrophages (TAM), which establish a
symbiotic relationship with tumour cells. The above tumour-derived factors positively modulate
TAM survival. From their own, TAM secrete growth factors, which promote tumour cell
proliferation and survival, regulate matrix deposition and remodelling and activate neo-
angiogenesis. (Figure and text from18)
71.3 Drug Delivery
The active pharmaceutical ingredient (API) is an important part of drug products. The
API is expected to cross tissues and cells, accumulate in target organs and cells, and express their
therapeutic effects. Sometimes the API may not accumulate in diseased tissues, resulting in weak
effects on target sites and side effects on healthy tissues.25,26 Thus, drug targeting has the
potential to overcome these problems. Many drug carriers, such as micro- or nanoparticles,
liposomes and micelles, have been used for their enhanced permeability and retention (EPR) in
tumors.27–29 The EPR-effect is observed primarily in tumor tissues for macromolecular
compounds such as liposomes and polymeric micelles.30 The EPR-effect results from an
enhanced permeability of tumor blood vessels. Factors such as VEGF and prostaglandins can
increase the vascular permeability, which allows the extravasation of macromolecules from
blood vessels.26,30 Additionally, tumor tissues are lack of functional lymphatic drainage, which
allows the drug carriers to be retained in the diseased tissue.31 As a result, these drug carriers
allow drugs to obtain a high accumulation and long retention time in tumor tissues.
Passive targeting takes advantage of the EPR-effect and is affected by the molecular
weight, shape, and surface chemistry of drug carriers.26,32,33 For example, the circulation time
and cellular uptake efficiency can be altered through surface modification of particles.
Liposomes coupled with poly(ethylene glycol) (PEG) chains enhanced circulation time from
minutes up to 48 hours compared to naive liposomes.34 To further increase targeting efficient ,
the surface of drug carriers were decorated by coupling with affinity-targeting moieties, such as
sugars, peptides, and antibodies.28,35 For example, folate receptors are expressed on a variety of
tumor cells, thus the attachment of folate onto poly(lactic-co-glycolic acid) particles surface
resulted in increased cellular uptake and improved therapeutic effects.34
81.4 Internalization of Drug Delivery Vehicles by Macrophages
Synthetic polymers, liposomes, micelles, and micro- or nanoparticles are extensively
used in drug delivery as carriers that can provide a safe and stable environment for drugs from
degradation while increasing their circulation time. They can have good biocompatibility and
tunable surface characteristics based on materials selection. In this way, These drug carriers can
improve the amount of drug that accumulates in the tumor while increasing the time spent in the
therapeutic window.36–38 Hydrogel microparticles are one type of drug carriers, which possess
crosslinking structures, allowing them to load and entrap drugs effectively. Hydrogen bonding
between hydrogels and water results in a high water content similar to living tissue and
hydrophilic structure.36
Physicochemical properties of microparticles can affect their drug loading and release
ability, as well as delivery effectiveness. The drug loading ability might be influenced by surface
interactions, including physical absorption, covalent binding, and the entrapment between drugs
and polymer matrix.39 Drug release rates are affected by different parameters such as the local
pH, the crosslinking density of materials, and the interaction between the drug and the material
systems.40 Release mechanisms include diffusion, swelling, and erosion. Targeting is not only
related to materials properties but also to the macrophage response.41–43 Once these particles
enter the physiological environment, proteins will adsorb onto the material surface, which can be
recognized by macrophages. The composition of protein on the surface of the material is
determined by the size, shape, and surface of the particle.41 The energy difference between the
adhesion energy gain from particles and cell membranes and the deformation-energy loss from
the lipid layer can determine the particles uptake efficiency.42
9There are several internalization pathways that can be used to deliver drugs to cells
including pinocytosis, receptor-mediated endocytosis, and phagocytosis.44 The uptake of solutes
or fluid is usually done through pinocytosis while the macromolecules and small particles are
typically internalized through receptor-mediated endocytosis. Phagocytosis is the principal
pathway for internalization of foreign substances by macrophages. These particles are typically
larger than 0.5 µm.44,45 During this process, a complex set of receptors are engaged and play a
function on recognition, initiation or inhibition of internalization, microbe killing, and mediation
of chemokines and cytokines to regulate innate and adaptive immune response.46 Different
foreign molecules will bind with different receptors and affect the internalization response.
Usually the secretion of pro-inflammatory signals, which provide an antimicrobial environment,
accompanies phagocytosis. For example, LPS and IFN-γ are secreted by macrophages before the
digestion of bacteria and can acidify the phagosome environment and decrease the bacterial
viability.44,46 Multiple receptors that are engaged in phagocytosis of microbes and their signaling
functions are shown in Figure 1.4.
Surface properties such as shape, size, and surface chemistry of the particles can affect
macrophages internalization based on the nonspecific recognition by macrophage
receptors.41,47,48 In general, spherical, high positively or negatively charged particles that are
hydrophobic will enhance the macrophage uptake while particles with an elongated shape that
are neutrally charged and hydrophilic will inhibit uptake.49 The first event that will occur when
particles are injected into living organisms is the adsorption of proteins. There are thousands of
types of proteins in the blood and each of them has the potential to interact with the particle
surface. Once proteins are adsorbed on the particle surface, they act as opsonins to aid in
recognition by macrophages. Since particles with different sizes and surface chemistry affect
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protein absorption and lead to different particle-protein complexes, which influences the cell
recognition response, materials chemistry can alter internalization by macrophages.50
Figure 1.4. Receptor and signaling interactions during phagocytosis of microbes. Multiple
receptors simultaneously recognize microbes both through direct binding and by binding to
opsonins on the microbe surface. Receptor engagement induces many intracellular signals, and
several molecules are utilized in many pathways. Signaling during phagocytosis may
subsequently serve to activate or inhibit further phagocytosis and microbe-induced responses.
Many pathogenic microbes actively regulate phagocyte responses. (Figure and text from 46)
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1.5 Material Selection for Drug Delivery
Environmentally sensitive hydrogels are widely used in drug delivery systems owing to
their ability to undergo a reversible phase change under external stimuli. There are many types of
environmentally sensitive hydrogels including temperature sensitive, pH sensitive, glucose
sensitive, light-sensitive etc.51–53 Temperature-sensitive hydrogels undergo a phase transition
when the temperature is changed. A lower critical solution temperature (LCST) system means
that below a critical temperature, the system is well dissolved. For some polymers, this results
from the hydrogen bonding between the solvent and solute. Once above the LCST, the two
phases separate.54 Inverse behavior occurs for upper critical solution temperature systems. This is
due to the Gibbs free energy of phase mixing changing from negative to positive. Poly(N-
isopropylacrylamide) (pNIPAm) based hydrogels have been extensively studied as a drug carrier
due to its LCST, small size, and good biocompatibility.55,56 Pure pNIPAm microgels have an
LCST around 32°C, which is close to body temperature,53,56,57 meaning that once the pNIPAm
hydrogel is injected in vivo, the hydrogel volume will shrink. At room temperature, pNIPAm
forms a sponge-like structure, allowing drugs to be entrapped by the hydrogel and release slowly.
The attachment between drugs and carriers can be either a physical or chemical interaction.
1.6 Conclusions
Macrophages are phagocytes in the immune system that digest foreign particles and
secrete cytokines. They can be classified into M1 and M2 state. M1 macrophages are pro-
inflammatory and help suppress tumor growth. M2 macrophages produce the growth factors and
aid in tissue repair and tumor growth. TAMs are mostly found near the tumor area and aid tumor
promotion. These cells are considered as potential drug targets for cancer treatment. Targeted
delivery can be achieved by drug delivery vehicles. Materials, such as micro- or nanoparticles,
12
micelles and liposomes, have been used as drug carriers. These drug delivery vehicles as well as
their effects on macrophage internalization have been widely studied. 58,59 However, systematic
studies investigating the role of materials properties on macrophage are necessary to develop
design principles to rationally construct novel and more efficient drug carriers. Some of the
advantages of pNIPAm particles are good biocompatibility, hydrophilicity, and tunable network
structures which make them attractive for drug delivery.56 Since macrophage phagocytic
responses are determined by the physicochemical properties of materials, increasing the
materials space will allow us to better understand how these parameters influence internalization
by macrophages.
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CHAPTER 2 SYNERGISTIC INTERNALIZATION OF PNIPAM MODIFIED
PARTICLES BY MACROPHAGES
Cellular uptake of drug carriers is influenced by materials properties. Here, engineered
biomaterials were investigated for applications in drug delivery to target macrophages. Hydrogel
microparticles, based on their small size and high water content, were used as carriers to deliver
drugs through interactions between their surface ligands and macrophages. Macrophages are
plastic cells that can aid in tumor progression when they are in the tumor microenvironment. Our
previous studies have shown that materials parameters, such as the number of hydrogen atoms
and 2° carbon atoms can positively impact M1 macrophage internalization. In this study, we
expand the materials space through pairwise combinations of p(N-isopropyl acrylamide-co-
acrylic acid) (pNIPAm) polymer particles with different surface modifications. The analysis
found that six pairs of the combinations in our library have obvious synergistic effects on cellular
uptake. Therefore, by improving the materials space physicochemical properties positively
influencing macrophage internalization can be extracted and can improve understanding on how
materials properties can be exploited for drug delivery.
2.1 Introduction
Macrophages are functionally heterogeneous, existing on a spectrum of activations.
These phenotypes can be simplified into two polarizations: classically activated macrophages
(M1 macrophages) and alternatively activated macrophages (M2 macrophages). Factors, such as
bacteria and IFN-γ produced from other immune cells, can stimulate monocytes into M1
macrophages. After stimulation M1 macrophages secrete pro-inflammatory cytokines and
chemokines such as TNF-α and IL-6 to aid antigen presentation, cell killing, and tumor
suppression.60,61 Macrophages are activated to M2 macrophages through IL-4 and IL-13. M2
14
type cells secrete low levels of pro-inflammatory cytokines and high levels of IL-4 and VEGF
which promote tissue repair, tumor cell growth, and reduce anti-tumor activities.60,61 TAMs
typically exhibit an M2 type response, which promote tumor cell growth and angiogenesis.22
Macrophages can be recruited by cytokines and chemokines to the tumor site. The
microenvironment around tumor tissues can polarize them into TAMs.13 TAMs are considered
potential drug targets for anti-tumor therapies.
The natural capacity of microparticles to target macrophages makes them an ideal choice
for delivering drugs to TAMs. Some examples of potential drug carriers are liposomes, micro-
and nanoparticles and micelles. Microgels have good biocompatibility based on their tissue-like
structure and high water content. Additionally, drug delivery carriers can increase circulation
time, reduce the side effects, and increase accumulation in tumor sites based on permeation and
retention effects.62,63 These particles can also be easily tuned to exhibit different materials
properties. The surface characteristics can determine their circulation time and the cellular
uptake efficacy.
Recent studies have demonstrated that materials properties such as particle size, charge,
geometry, and chemical properties can affect macrophages internalization.42,47,64 Negatively
charged, hydrophobic particles can enhance macrophage uptake.49 Once materials enter the
blood stream, various proteins will adsorb on the particle surface and will aid recognition by
macrophages.42,49 In this way, further elucidating how surfaces chemistries alter macrophage
uptake would vertically improve rational design of drug delivery vehicles.
In this study, pNIPAm copolymer particles have been used as a model drug carrier and
were modified with 13 different functional groups. The cytotoxicity of naïve macrophages to the
15
synthesized materials was analyzed. The swelling ratio of each material was also measured. The
goal of this study was to expand the materials space by combining materials with different
surface chemistry and analyze their influence on internalization through pair-wise combinations.
The results were compared with single particle internalization studies and the synergistic effects
on these materials were mapped. Correlations between materials properties with internalization
and synergistic effects were examined and trends uncovered may improve rational design of drug
delivery vehicles to macrophages.
2.2 Materials and Methods
Fresh deionized water (Milli-Q, Thermo Scientific Nanopure) was used throughout this
study. All materials were purchased from Sigma and used as received unless otherwise described.
Chemicals for materials synthesis and modification are listed below: N-isopropylacrylamide
(NIPAm), acrylic acid (AAc), N,N-methylenebis(acrylamide) (BIS), potassium persulfate (KPS)
(Fisher Scientific), 1-ethyl-3(-3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)
(Oakwood Chemical), dimethyl sulfoxide (DMSO) (Fisher Scientific), 3-butenylamine (Santa
Cruz Biotechnology), aminoacetaldehyde dimethyl acetal (Alfa Aesar), malonamide (TCI),
glycidamide (Fluka), tert- butyl 4-aminobutanoate (Ark pharm), c-[1,4]Dioxan-2-yl-methylamine
(Matrix Scientific), 1-amino-4-oxocyclohexanecarboxylic acid ethylene ketal, 2-aminoethyl
methyl sulfone hydrochloride (Chem-Impex), 4-amino-3-penten-2-one (Alfa Aesar),  2,4-
dinitrophenoxyamine, 3- aminobenzamide oxime, 3-amino-1-propanesulfonic acid (Acros
Organics), (aminomethyl)phosphonic acid. Chemical for cell viability test is
methylthiazolyldiphenyl tetrazolium bromide (MTT, Acros).
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2.2.1 Polymer synthesis and modification
BIS (0.18 g), NIPAm (2.4 g) and AAc (157 μl) were dissolved in 100 ml H2O and stirred
under nitrogen in a 250 ml round-bottom flask for 30 min at 70°C. After this, 10 ml KPS (20
mg/ml) was added to the flask and allowed react for 4 h. Then, the suspension was slowly cooled
to room temperature, filtered with P5 grade filter paper, and dialyzed against H2O for 48 h.
PNIPAm particles were lyophilized (Labconco, 4.5L).
For chemical modifications of the particles, 5.4 ml phosphate buffer (PBS, diluted from
phosphate buffered saline-10X solution to 0.1 M, pH 7.4, Fisher Scientific), 600 μl EDC (200
mg/ml), 12 mg modifiers, and 1.2 ml pNIPAm particles (5% w/v) were vortexed and reacted
overnight at room temperature. After this, particles were dialyzed against H2O overnight,
lyophilized and reconstituted at 1% w/v.
2.2.2 Swelling ratio
Swelling ratios were measured for all 13 pNIPAm modified particles and the unmodified
pNIPAm particles. In centrifuge tubes 10 mg (Wd ) freeze-dried particles were weighed. Dry
particles were allowed to equilibrate in 1 ml (1:1 DMSO: water) solution at 4 °C for 24 h. After
swelling, tubes were centrifuged at 8,000 g for 10 min. Solvent was carefully aspirated out and
the mass of the gel was recorded (Ws ). Swelling ratio of each particle was calculated using the
equation below:
Swelling ratio= (1)WsWd
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2.2.3 Cell viability
RAW 264.7 cells (ATCC, Manassas, VA) were cultured at 37°C with 5% CO2 in
Dulbecco’s modified Eagle’s medium (Thermo Scientific) supplemented with 10% fetal bovine
serum, 100U/L penicillin, and 100μg/ml streptomycin, to be referred to as complete medium
(CM). Cells (1.3 × 105 cells/cm2 with 500 μl medium in every well except negative control) were
seeded in clear 24-well plates for 24 h at 37°C. After incubating, the media was carefully
aspirated, and the same amount of CM was added to each well. To each well, 10 μl (0.0625%) of
each particle was added into each column. A control set of experiments was done in the absence
of particles. After 24 h incubation, the media was aspirated and 50 μl of 5 mg/ml MTT and 500μl
CM without phenol red were added to the plate and incubated for 2 h. The insoluble formazan
crystals were dissolved in 500 μl DMSO after aspirating 425 μl of CM. The optical density (OD)
at 540nm was measured using a plate reader (BioTek Synergy HT Multidetection Microplate
Reader) with a reference at 690nm. Cells were normalized to the positive control consisting of
cells without particles.
2.2.4 Fluorescent particles
To determine the loading efficiency, the polymer particles (1%) were mixed with FC
(Fluorescein, 1 mg/ml in DMSO) in a 1:1 ratio. After incubating for two days at 4°C, all
materials were centrifuged at 8,000 g for 10 min. The supernatant was carefully transferred to
black 96-well plates. The standard curve was made through serial dilutions of FC loaded
particles in 1:1 H2O:DMSO. An excitation/emission of 480/520 nm was used to evaluate the
loading efficiency by recording the amount of FC not loaded into the particles.
For the cellular uptake experiments, the polymer particles were mixed with PBS and FC
in a 1:3:4 (particles: PBS: FC) ratio. After a two-day incubation at 4°C, all materials were
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centrifuged at 3,000 g for 5 min. The supernatant was carefully aspirated and the same volume of
PBS was added to maintain the particle concentration of 0.125%.
2.2.5 Cellular uptake and cold binding
Cells (1.6 ×105 cells/cm2 with 100 μl CM in every well except negative control) were
seeded in black 96-well plates for 24 h at 37 °C. The media was carefully aspirated and 50 μl of
0.125% w/v FC loaded modified pNIPAm particles and 50 μl CM were added to each well and
incubated for 4 h at 37°C for internalization experiments or for 4 h at 4°C for cold binding
experiments. Unmodified pNIPAm particles were used as a positive control. Negative controls
consisted of FC particles without cells. After the 4 h incubation, the particle suspension was
removed and immediately quenched with trypan blue (0.25 mg/ml) for 1 min. An
excitation/emission of 480/520nm emission was used to record the phagocytic activity using a
plate reader. The fluorescence intensity (FI) was normalized to the loading efficiency (LE) for
each particle and the fluorescence level of macrophages incubated with unmodified pNIPAm
particles. The normalized fluorescence was calculated using the equation below:
Normalized fluorescence= FI
LE
×
LE of pNIPAm
FI of pNIPAm
(2)
2.2.6 Statistics and data analysis
Statistical analysis was performed using JMP statistical software. Pair-wise comparisons
were analyzed with Student’s t test and connecting letters report was generated. Differences were
considered statistically significant for p < 0.05. Principal component analysis was conducted to
analyze the correlation among multiple variables. Two axes represent the maximum variance.
The relationship between each variable can be observed through projections of the first and
second principal components in two-dimensional shape.
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2.3. Results
2.3.1. Synthesis and characterization
After synthesis of the pNIPAm particles, the particles were modified with the 13 different
molecules shown in Figure 2.1. The modified particles were characterized for their swelling ratio
and FC loading efficiency (Figure 2.2). Details of multiple comparisons for this data are shown
in Table 2.1, 2.2. The swelling ratio ranged from 4.4 to 6.9. A wide range of loading efficiencies
from 10% to 71% results from the surface modifications. The swelling behavior of materials can
affect their drug loading efficiency.65,66 However, from the data shown in Figure 2.2, there is no
trend between these two parameters (R2 = 0.2). Amide, ester and ketone have similar loading
efficiencies and swelling ratios (p > 0.05). However, acetal, amide, epoxide, ketal, ketone, and
sulfonic acid have similar swelling ratios (p > 0.05) but their loading efficiencies vary. Acetal
has the lowest loading efficiency while amide and ketone have the highest loading efficiency.
Figure 2.1. The chemical structures of the 13 different modifiers coupled to pNIPAm particles.
The functional group names listed below the structures are used to describe the modified
particles throughout this work.
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Figure 2.2. Swelling ratio and percent loading efficiency of each modified particle. Swelling
data represents the mean value of five replicates for each sample ± standard deviation; loading
efficiency data represents the mean value of six replicates for each sample ± standard
deviation. For the swelling ratio, * indicates p < 0.05 compared to pNIPAm particles. For the
loading efficiency, all modified particles are statistically different with pNIPAm particles (p <
0.05).
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Table 2.1. Connecting letters report for swelling ratio for modified pNIPAm particles
Materials
phosphonic acid A
nitro A B
ether A B C
pNIPAm A B C
oxime A B C D
sulfone B C D
alkene C D E
ester D E
amide E
ketone E
sulfonic acid E
epoxide E
ketal E
acetal E
Levels not connected by the same letter are significantly different (p<0.05)
Table 2.2. Connecting letters report for loading efficiency for modified pNIPAm particles
Materials
sulfone A
ketone B
amide B
ester B
sulfonic acid C
epoxide D
ketal D
nitro E
oxime E
pNIPAm F
phosphonic acid G
acetal G H
ether H
alkene I
Levels not connected by the same letter are significantly different (p<0.05)
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2.3.2. Cell viability
Drug carriers must be cytocompatible. The viability of RAW 264.7 macrophages in the
presence of the modified particles was tested and is shown as a percentage of cell viability of
cells in the absence of particles (Figure. 2.3). All materials resulted in 90% macrophage viability,
indicating that these materials have little toxic effects on this cell line.
Figure 2.3. The cell viability of naïve macrophages exposed to 14 different modified pNIPAm
particles. All samples were normalized to naïve cells without particles. (Data represents the
mean value of four replicates for each sample ± standard deviation)
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2.3.3. Particle internalization by non-activated macrophages
A library of pairwise combinations of modified pNIPAm particles were tested for their
ability to be internalized by macrophages. The internalization of 14 modified pNIPAm particles
and their combinations (91 pairs) by naïve macrophages were tested and analyzed. Fluorescently
loaded particles were used for the cellular uptake test. All fluorescence intensity data was
normalized to the amount of fluorescence of each particle and to the fluorescence of
macrophages incubated with unmodified pNIPAm particles. Figure 2.4A shows the
internalization of single particles. Figures 2.4B to 2.4O illustrate the internalization of the
combined particles. Details of multiple comparisons for this data are shown in Table 2.3.
pNIPAm particles increased the cellular uptake when combined with acetal, ether, nitro, and
oxime (p < 0.05) compared to control. The remaining combinations with pNIPAm were
statistically similar to the control (p > 0.05) (Figure 2.4B). Combinations of acetal with pNIPAm,
alkene, ester, ether, ketal, phosphonic acid, and sulfone increased internalization compared to the
control (p < 0.05), while decreased internalization was observed for acetal in combination with
amide, epoxide, and ketone (p < 0.05) (Figure 2.4C). Alkene exhibited increased internalization
in combination with acetal, ether, and sulfone (p < 0.05), while a decreased level was observed in
combination with ester, nitro, oxime, and sulfonic acid (p < 0.05), all compared to control
(Figure 2.4D). Amide, when paired with ether, ketal and phosphonic acid, resulted in increased
internalization (p < 0.05) and decreased internalization with acetal, epoxide, oxime, and sulfonic
acid (p < 0.05) compared with control (Figure 2.4E). Combinations with epoxide resulted in no
increase in internalization (p > 0.05) (Figure 2.4F). Ester increased cellular uptake in
combination with acetal and oxime compared to control (p < 0.05) and decreased cellular uptake
in combination with alkene, nitro, sulfone, and sulfonic acid compared to control (p < 0.05)
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(Figure 2.4G). Ether increased internalization with other six particles: pNIPAm, acetal, alkene,
amide, oxime, and phosphonic acid compared to control (p < 0.05). Decreased internalization
was observed for ether in combination with ketone and sulfone compared to control (p < 0.05)
(Figure 2.4H). Ketal paired with acetal, amide, oxime and phosphonic acid increased cellular
uptake compared with control (p < 0.05), while combinations with epoxide, sulfone, and sulfonic
acid decreased internalization compared with control (p < 0.05) (Figure 2.4I). Ketone increased
the internalization when combined with phosphonic acid compared with control (p < 0.05)
(Figure 2.4J). Nitro increased cellular uptake when combined with pNIPAm and phosphonic acid
compared with control (p < 0.05), while decreased internalizattion occurred with alkene, epoxide,
ester, and ketone compared with control (p < 0.05) (Figure 2.4K). Oxime paired with pNIPAm,
ester, ether, ketal, phosphonic acid, sulfone or sulfonic acid increased cellular uptake compared
with control (p < 0.05), while decreased were observed in combination with alkene, amide, and
epoxide compared to control (p < 0.05) (Figure 2.4L). Phosphonic acid enhanced internalization
in combination with acetal, amide, ether, ketal, ketone, nitro, and oxime compared with control
(p < 0.05) (Figure 2.4M). Sulfone increased cellular uptake in combination with acetal and
oxime compared to control (p < 0.05), while combinations with alkene, epoxide, ester, ether, and
ketal resulted in decreased internalization compared to control (p < 0.05) (Figure 2.4N). Sulfonic
acid enhanced internalization only when combined with oxime compared to control (p < 0.05)
(Figure 2.4O).
Overall, the highest internalization level was observed from combinations of phosphonic
acid/oxime, phosphonic acid/ether, sulfonic acid/oxime, phosphonic acid/acetal, ether/oxime, and
amide/phosphonic acid compared to control (p < 0.05). While the lowest internalization ability
was observed from sulfonic acid/ester, sulfonic acid/ketal, sulfone/epoxide, sulfonic acid/ketone,
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ketone/ether, and ester/nitro compared to control (p < 0.05). In total, there are 24 combinations
with increased the cellular uptake, while 25 combinations decreased internalization compared to
control (p < 0.05). Among those 24 combinations with the highest internalization, particle acetal,
ether, oxime, and phosphonic acid have the most frequent occurrence. Alkene, epoxide, ketone,
sulfone, and sulfonic acid were observed most frequently from 25 combinations that decreased
internalization.
Figure 2.4. Particle internalization by naïve macrophages. The fluorescence level of FC
labeled particles internalized by naïve macrophages is shown. Data represents the mean value
of ten replicates for each sample ± standard deviation. * indicates p < 0.05 compared to
pNIPAm particles.
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Figure 2.4. Continued.
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Figure 2.4. Continued.
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Figure 2.4. Continued.
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Figure 2.4. Continued.
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Figure 2.4. Continued.
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Figure 2.4. Continued.
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Figure 2.4. Continued.
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Table 2.3. Connecting letters report for normalized fluorescence for combined particles
Material
phosphonic acid/oxime A
phosphonic acid/ether B
sulfonic acid/oxime C
phosphonic acid/acetal C D
oxime/ether C D
amide/phosphonic acid D
ester/acetal E
sulfone/oxime E F
nitro/phosphonic acid E F G
ketal/acetal F G H
ester/oxime G H I
sulfone/acetal G H I J
pNIPAm/oxime G H I J
alkene/acetal H I J K
phosphonic acid/ketal H I J K L
amide/ether H I J K L
pNIPAm/nitro I J K L M N
ketone/phosphonic acid I J K L M
amide/ketal J K L M N O
pNIPAm/acetal J K L M N O
alkene/ether K L M N O P
pNIPAm/ether L M N O P Q
oxime/ketal M N O P Q R
ether/acetal M N O P Q R S
nitro/oxime M N O P Q R S T
nitro/amide M N O P Q R S T U
pNIPAm/amide N O P Q R S T U V
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Table 2.3 Continued.
Material
ketone/sulfone O P Q R S T U V W
ester/ketal O P Q R S T U V W
pNIPAm/ester P Q R S T U V W X Y
pNIPAm/alkene P Q R S T U V W X
ester/phosphonic acid Q R S T U V W X Y Z
nitro/ketal R S T U V W X Y Z A1
ester/epoxide S T U V W X Y Z A1 B1
nitro/sulfone S T U V W X Y Z A1 B1
ketone/ketal S T U V W X Y Z A1 B1 C1
nitro/acetal S T U V W X Y Z A1 B1 C1
nitro/sulfonic acid T U V W X Y Z A1 B1 C1
phosphonic acid/epoxide T U V W X Y Z A1 B1 C1
pNIPAm T U V W X Y Z A1 B1 C1
alkene/ketal U V W X Y Z A1 B1 C1 D1
nitro/ether T U V W X Y Z A1 B1 C1 D1 E1
ester/ketone V W X Y Z A1 B1 C1 D1 E1
pNIPAm/sulfonic acid V W X Y Z A1 B1 C1 D1 E1 F1
phosphonic acid/alkene V W X Y Z A1 B1 C1 D1 E1 F1
pNIPAm/epoxide V W X Y Z A1 B1 C1 D1 E1 F1 G1
ester/amide V W X Y Z A1 B1 C1 D1 E1 F1 G1
amide/sulfone V W X Y Z A1 B1 C1 D1 E1 F1 G1
Material
alkene/epoxide W X Y Z A1 B1 C1 D1 E1 F1 G1 H1
ketal/ether W X Y Z A1 B1 C1 D1 E1 F1 G1 H1
ether/epoxide W X Y Z A1 B1 C1 D1 E1 F1 G1 H1 I1
pNIPAm/ketone X Y Z A1 B1 C1 D1 E1 F1 G1 H1 I1 J1
ketone/oxime X Y Z A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1
sulfonic acid/epoxide X Y Z A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1
sulfonic acid/phosphonic
acid
Y Z A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1
sulfonic acid/acetal Z A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1
sulfonic acid/sulfone Z A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1
ester/ether Z A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1
phosphonic acid/sulfone Z A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1
ketone/alkene A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1
oxime/acetal Z A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1
sulfonic acid/ether A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1
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Table 2.3 Continued.
Material
ketone/amide A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1 O1
amide/alkene A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1 O1
pNIPAm/sulfone A1 B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1 O1
pNIPAm/phosphonic acid B1 C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1 O1
pNIPAm/ketal C1 D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1 O1 P1
sulfonic acid/amide D1 E1 F1 G1 H1 I1 J1 K1 L1 M1 N1 O1 P1
ester/sulfone E1 F1 G1 H1 I1 J1 K1 L1 M1 N1 O1 P1 Q1
ketone/acetal F1 G1 H1 I1 J1 K1 L1 M1 N1 O1 P1 Q1 R1
alkene/oxime G1 H1 I1 J1 K1 L1 M1 N1 O1 P1 Q1 R1
Material
acetal/epoxide H1 I1 J1 K1 L1 M1 N1 O1 P1 Q1 R1 S1
amide/oxime I1 J1 K1 L1 M1 N1 O1 P1 Q1 R1 S1 T1
amide/epoxide I1 J1 K1 L1 M1 N1 O1 P1 Q1 R1 S1 T1
sulfone/ether I1 J1 K1 L1 M1 N1 O1 P1 Q1 R1 S1 T1
nitro/epoxide I1 J1 K1 L1 M1 N1 O1 P1 Q1 R1 S1 T1
alkene/sulfone I1 J1 K1 L1 M1 N1 O1 P1 Q1 R1 S1 T1
ketone/epoxide J1 K1 L1 M1 N1 O1 P1 Q1 R1 S1 T1
ketal/epoxide K1 L1 M1 N1 O1 P1 Q1 R1 S1 T1 U1
sulfone/ketal L1 M1 N1 O1 P1 Q1 R1 S1 T1 U1
oxime/epoxide M1 N1 O1 P1 Q1 R1 S1 T1 U1
ester/alkene N1 O1 P1 Q1 R1 S1 T1 U1
amide/acetal O1 P1 Q1 R1 S1 T1 U1 V1
sulfonic acid/alkene P1 Q1 R1 S1 T1 U1 V1
nitro/ketone Q1 R1 S1 T1 U1 V1
nitro/alkene Q1 R1 S1 T1 U1 V1
ester/nitro Q1 R1 S1 T1 U1 V1
ketone/ether R1 S1 T1 U1 V1
sulfonic acid/ketone S1 T1 U1 V1
sulfone/epoxide T1 U1 V1
sulfonic acid/ketal U1 V1
sulfonic acid/ester V1
Levels not connected by the same letter are significantly different (p<0.05)
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To confirm the fluorescent signal in Figure 2.4 resulted from internalization, cold
binding experiments were performed. Figure 2.5 shows the fluorescence level of FC loaded
particles incubated with naïve macrophages at 4 °C. Cells at 4 °C are unable to internalize
particles. Details of multiple comparisons for this data are shown in Table 2.4
Figure 2.5. Fluorescence level of FC loaded particles incubated with macrophages at 4 ℃. Data
presents the mean value of ten replicates for each sample ± standard deviation.* indicates p <
0.05 compared to pNIPAm particles.
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Table 2.4. Connecting letters report for internalization at 4℃ in naïve macrophages.
Materials
sulfone A
ketal B
ester B C
ketone B C
amide B C
alkene C
sulfonic acid C D
nitro D E
epoxide E F
oxime E F
ether E F
acetal E F
phosphonic acid E F
pNIPAm F
Levels not connected by the same letter are significant different (p<0.05).
2.3.4. Synergistic effects on different combined materials
The main purpose of this study is to examine the synergistic effects of pair-wise
combinations of materials on internalization, as described in equation 3.
(3)
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where IA and IB designate the normalized fluorescence for two different materials (from
Figure 2.4A). IA+B is the normalized fluorescence of the mixture of particles (from Figure 2.4B to
2.4O). The synergistic effect is characterized by an enhanced effect when two or more items are
used in combination compared to using them alone. It is often used in drug delivery studies to
evaluate the efficiency of drug delivery vehicles when two or more are combined.67 In this study,
the fluorescence intensity of pair wise combinations were compared to single additions of
particles in the presence of macrophages. The internalization of 91 paired particles and 14
individual particles were analyzed to determine the synergistic effect of each pair-wise
combination.
The synergistic relationship for the library of combinations is shown in Figure 2.12. The
observed value is IA+B and 0.5IA + 0.5IB represents the expected value. The figure also shows the
relationship between 0.5IA + 0.5IB and IA+B. The line represents an additive relationship between
the combined materials. Data points above the line exhibit synergistic effects while data below
the line exhibit antagonistic effects. Most pairs were accumulated near the line while six
mixtures exhibit synergistic effects: oxime/phosphonic acid (1), ether/phosphonic acid (2),
oxime/sulfonic acid (3), oxime/ether (4), acetal/phosphonic acid (5) and amide/phosphonic acid
(6) and are labeled as such in Figure 2.5.
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Figure 2.6. Experimentally measured normalized fluorescent values for 91 combinations
plotted against predicted values based on linear averages of normalized fluorescent values for
individual particles. Data represents the mean value of ten replicates for each sample ±
standard deviation. Labeled particles are: oxime/phosphonic acid (1), ether/phosphonic acid
(2), oxime/sulfonic acid (3), oxime/ether (4), acetal/phosphonic acid (5) and
amide/phosphonic acid (6)
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2.3.5. The effect of materials properties on macrophage internalization
Principal component analysis was applied to the dataset to determine correlations
between the physicochemical properties of the molecules in used to modify pNIPAm particles
and macrophage internalization (Figure 2.1). This analysis results in a multidimensional data set,
of which the first two principle components were used to generate a two-dimensional plot
(Figure 2.6) to better extract relationships between the materials properties and the
internalization of the particles by macrophages. LogP and LogD are a measure of the octanol-
water distribution coefficient, which describes lipophilicity. LogD can be measured at different
pH values. BCF is the bioconcentration factor that describes the ability of a chemical to
accumulate in organisms when the surrounding medium is water. KOC is the partition coefficient
between organic carbon and water, measuring the extent of chemical sorption on organic carbon.
Polar surface area of a molecule is correlated with the ability of molecules to penetrate cell
membranes.68 The swelling ratio, surface tension, boiling point, vapor pressure, and enthalpy of
vaporization are properties that depend on the extent of secondary bonding. Secondary bonding,
such as H bonding, can affect hydrophilicity, which may further influence cellular uptake. A
positive correlation was observed between H bond acceptors and the synergistic effect of
particles on macrophage internalization. Additionally, the polar surface area positively affects
the synergistic effect.
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Figure 2.7. Observation and loading plots of physicochemical materials properties and their
influence on macrophage internalization. PC1 explains 33.8% data variance and PC2 explains
22.4% data variance, which represents >50% of the original data information. (A) Observation
plots of the 91 modified pNIPAm particles combinations and (B) loading plots of the
physicochemical properties of the modifiers in PC space.
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2.4 Discussion
2.4.1 The effect of material swelling ratio on loading efficiency
The swelling behavior of the library synthesized here was measured and compared to
their drug loading efficiencies. As shown in Figure 2.2, different swelling ratios were measured
for modified particles acetal, amide, epoxide, ester, ketal, ketone and sulfone compared to
pNIPAm particles (p < 0.05). The swelling behavior of polymers is related to the hydrogen-
bonding interaction with the water.69 Therefore, distinct swelling behavior can be observed after
chemical modification. The loading efficiency of materials can be affected by particle volume,
polymer concentration, and polymer-drug interaction.70–72 Polymers modified by different
molecules result in different binding affinities between the carrier and drugs. As an example,
different functional groups might have more or less ionic sites that lead to stronger or weaker
interactions with FC.72 The modified pNIPAm particles studied here showed no trend between
their swelling ratios and loading efficiencies
2.4.2 The effect of materials properties on naïve macrophages internalization and
synergistic effects
The internalization of particles by macrophages is determined in part by the interactions
of adsorbed proteins on particles surfaces.41,42 Protein adsorption is based on the interactions
between proteins and particle ligands. Thus, particles with different surface properties will result
in different protein adsorption. These proteins can act as opsonins can aid in recognition by
macrophages. Macrophages have a variety of surface receptors that can bind to different
opsonins and trigger a wide range of intracellular responses are such as the phagocytic process.46
Therefore, by changing the surface chemistry, macrophage internalization can be altered.
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Our previous studies showed that the hydrophobicity of materials, the number of CH2
groups and sp2 carbon atoms can affect the alternative pathway of complement activation.64 It
was also observed that materials parameters such as the number of hydrogen atoms and sp2
carbon atoms have an influence on macrophages uptake.64 In order to expand the material library
and have a deeper understanding of the role of material surface on uptake by macrophages, this
work continues the focus on modified pNIPAm and investigates the synergistic internalization of
these particles. Six combinations were found to result in synergistic internalization by
macrophages: acetal/phosphonic acid, amide/phosphonic acid, ether/phosphonic acid,
oxime/phosphonic acid, oxime/ether, and oxime/sulfonic acid.
Certain particle combinations were found to increase or decrease internalization. Acetal,
ether, oxime, and phosphonic acid generally result in enhanced internalization, while alkene,
epoxide, ketone, sulfone, and sulfonic acid generally reduce internalization. This trend may
result partly from hydrophilicity. Hydrophilic surfaces evade recognition and phagocytosis by
macrophages, which results in inefficient cellular uptake compared to hydrophobic materials.49
In this case, epoxide, ketone, sulfone and sulfonic acid are more hydrophilic, and thus result in
lower cellular uptake. Oxime is more hydrophobic which indicates higher internalization ability.
Acetal, alkene, ether, and phosphonic acid, do not follow the above trend in that alkene
reduces internalization and is hydrophobic. Conversely, acetal, ether, and phosphonic acid
increase internalization and are hydrophilic. This result can be explained by the zeta potential.
More negatively charged surfaces result in more efficient cellular uptake. 49,64,73 Previous studies
have shown that acetal, ether, and phosphonic acid were negatively charged, while alkene was
modestly positively charged.64 Overall, these results indicate that macrophage internalization can
be altered by changing particle surface properties.
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Synergy was observed for six combinations: oxime/phosphonic acid, ether/phosphonic
acid, oxime/sulfonic acid, oxime/ether, acetal/phosphonic acid, and amide/phosphonic acid .
Synergy resulting from combinations of individually modified particles may result from the
variety of surface receptors on macrophages, enabling binding with various ligands on the
particles.46 Single particles may interact only with certain receptors, however, when in
combination with other particles, multiple surface receptors may be activated. Amide and
sulfonic acid are two particles, which result in decreased internalization level. While amide is the
most hydrophilic modifier, sulfonic acid is also hydrophilic, resulting in the lowest
internalization level.
PCA shows that the synergistic effect has a positive relationship with polar surface area
and the number of H bond acceptors. H bonding plays an important role in the interactions
between drug carriers and cell membranes.74 An inability to form H bonds between the particles
and the cell surface will lead to inefficient cellular uptake.74 The polar surface area of molecules
has been shown to have a positive correlation with cell membrane permeability.68
2.5 Conclusions
By modifying pNIPAm surface chemistry, internalization by macrophages is altered and,
in some cases, improved. Chemical properties of the microparticles such as the number of H
bond acceptors and the polar surface area of the modifier were found to correlate with enhanced
macrophage internalization. Six pairs resulted in improved internalization compared to
unmodified pNIPAm. Combinations of oxime/phosphonic acid, ether/phosphonic acid,
oxime/sulfonic acid, oxime/ether, acetal/phosphonic acid and amide/phosphonic acid resulted in
synergistic effects on macrophage internalization. This might result from that the different types
of receptors on macrophages bind with multiple ligands on the particle combinations. In this
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way, we have expanded the material space to elucidate the role of materials properties in
macrophage internalization.
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